TP53 and cancer: Pharmacological recapitulation of p53 activity is currently exploited as a new therapeutic strategy to combat cancers.31 Several p53 reactivating small molecules have been developed and are currently undergoing preclinical or clinical developments.31,32 Their implementation in clinics, mainly due to the adverse pharmacokinetics, is still impeded.